4basebio is a Cambridge-based biotechnology company pioneering the use of synthetic DNA to enable next-generation therapeutics and vaccines. It produces GMP-grade synthetic DNA and mRNA using a proprietary enzymatic DNA synthesis platform, with application-specific constructs for gene therapies, genome editing, mRNA production and DNA vaccines.